Dr. Casey Means, President Donald Trump's nominee for surgeon general, faces an uncertain path to confirmation after two Republican senators told Politico they remain undecided on her nomination. Sens. Susan Collins of Maine and Lisa Murkowski of Alaska have not committed to supporting Means, and with Democrats expected to vote in opposition, any single Republican defection on the Health, Education, Labor, and Pensions Committee could sink her chances.
The math is unforgiving. One "no" from a committee Republican could prevent Means from reaching a full Senate vote at all.
According to Newsmax, Means faced pointed questions during her confirmation hearing, particularly on vaccines and their potential connection to autism. She did not rule out a link, telling the committee:
We do not know what, as a medical community, causes autism.
She added that "we should not leave any stones unturned" and emphasized that every parent and patient "needs to have a conversation with their physician." She also stated she was supportive of vaccines and said they save lives.
For Murkowski, this territory is familiar and frustrating. She pointed to Health and Human Services Secretary Robert F. Kennedy Jr., who was confirmed by the Senate last year, and suggested his commitments on vaccines have gone unfulfilled:
Last year when the secretary was going through his confirmations, he made certain assurances about vaccines that in fairness I am not seeing have been kept.
That line matters. It signals that Murkowski's hesitation on Means is not isolated. It is downstream of broader skepticism about whether the administration's health leadership is honoring the commitments made to secure Senate support in the first place.
Collins told Politico she has "not yet made a decision" and that she still has more questions for Means. Her focus during the hearing landed on different ground: Means' past use of psychedelic drugs and a book she authored in which she told readers to "consider psilocybin-assisted therapy."
Collins was direct: "I'm concerned."
Two senators, two different sets of objections. Collins is troubled by the personal conduct and public advocacy around psychedelics. Murkowski is fixated on institutional trust and whether vaccine assurances carry any weight. Together, they represent a confirmation headache that cannot be solved by addressing just one concern.
The picture is not entirely bleak. Six Republican committee members told Politico they support Means and would vote to confirm her:
Committee chairman Bill Cassidy, a physician and Republican senator from Louisiana, declined to comment on his vote. Sens. Tim Scott of South Carolina and Ashley Moody of Florida also declined to comment for the Politico report.
So the "yes" column has six names. The "undecided" column has two who are publicly voicing concerns. And three more senators, including the chairman, have not shown their cards.
None of this should surprise anyone who has watched the Senate over the past decade. Collins and Murkowski have long served as the Republican caucus's internal pressure relief valves, the members most likely to peel off on nominees or legislation that the rest of the conference supports. Their concerns are not always serious, but the pattern is consistent enough that it functions as its own kind of brand.
The question is whether this is posturing that resolves itself with a few private assurances or whether one or both senators have genuinely decided to draw a line. Murkowski's framing is notable because she tied her hesitation not just to Means but to Kennedy's track record. That suggests something harder to fix with a phone call.
The surgeon general's role is largely advisory and communicative. The office carries a bully pulpit, not regulatory authority. What the surgeon general says matters because of the platform, not because of the power to enforce. That makes the confirmation fight over Means partly a proxy war over something larger: who gets to shape the national conversation about health, and whether challenging medical orthodoxy is disqualifying or overdue.
Means represents a strain of health thinking that questions institutional consensus on chronic disease, nutrition, and pharmaceutical dependency. That perspective has found an enormous audience among Americans who feel the public health establishment failed them during COVID and has been slow to address skyrocketing rates of obesity, diabetes, and autoimmune conditions. Whether or not you agree with every claim Means has made, the appetite for someone willing to ask uncomfortable questions about American health outcomes is real and broad.
Collins and Murkowski are within their rights to press a nominee. That is the Senate's job. But the bar should be whether Means is qualified and honest, not whether her willingness to challenge conventional thinking makes establishment Republicans uncomfortable.
Six committee Republicans are ready to confirm. The holdouts have concerns. The chairman is quiet. The nomination lives or dies on whether two senators decide that asking hard questions about American health is a disqualifier or a job requirement.
